Kidney Disease Clinical Trials

Showing 1701-1720 of 1,850 trials

Certoparin in Renal Patients Undergoing Hemodialysis

NCT01179620

This study will assess the efficacy, safety and pharmacokinetics of certoparin when used to prevent clotting during hemodialysis.

Renal Dialysis

Novartis109 participantsStarted Nov 2010

Darmstadt, Germany • Elsenfeld, Germany • Flensburg, Germany +6 more locations

UNKNOWNPhase 4

RAAS Inhibitor Drugs in Dialysis Patients

NCT01635387

Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study was undertaken to ascertain whether the upstream of aliskirne, a direct renin inhibitor improves mortality and cardiovascular outcomes in these high-risk population.

HypertensionEnd Stage Renal Disease

University of Campania Luigi Vanvitelli350 participantsStarted Feb 2010

WITHDRAWNPhase 4

Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients

NCT01302236

The purpose of this study is to determine whether eplerenone is effective in the treatment of blood pressure, heart function, renal function in elderly hypertensive stage1 (eGFR\>=90ml/min/1.73m2) and stage2 (eGFR 60-89ml/min/1.73m2) chronic kidney disease (CKD) patients.

HypertensionChronic Kidney Disease.

Jichi Medical UniversityStarted Mar 2011

COMPLETEDPhase 2

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

NCT00434330

The purpose of this study was to determine the dose ranges of peginesatide administered intravenously or subcutaneously that maintained hemoglobin in participants on dialysis whose hemoglobin values were stable on epoetin (alfa or beta).

AnemiaChronic Kidney DiseaseChronic Renal Failure

Affymax91 participantsStarted Dec 2006

Burgas, Bulgaria • Pleven, Bulgaria • Plovdiv, Bulgaria +12 more locations

Certoparin in Renal Patients Undergoing Hemodialysis

RAAS Inhibitor Drugs in Dialysis Patients

Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Related Searches

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

N Acetyl Cysteine for Cystinosis Patients

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

Renal Tubular Acidosis in Incident Renal Transplant Recipients

Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Vitamin D Effect on Calcium Absorption on Persons on Hemodialysis

Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients

Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1